Abstract:
A hybrid battery power source for implantable medical use provides a generally constant low internal resistance during discharge and avoids voltage delays of the type that develop as a result of run down-induced resistance increase in Li/SVO cells. The hybrid battery power source utilizes two batteries or cells, one being a primary cell of relatively high energy density and the other being a secondary cell of relatively low internal resistance that is rechargeable. The primary and secondary cells are connected in a parallel arrangement via a voltage boost/charge control circuit that is powered by the primary cell and adapted to charge the secondary cell while limiting charge/discharge excursions thereof in a manner that optimizes its output for high energy medical device use. The energy storage capacitors of the medical device in which the hybrid battery power source is situated are driven by the secondary cell. The primary cell is used to as an energy source for recharging the secondary cell.
Abstract:
A high-energy power source with low internal self discharge for implantable use includes a multiplicity of rechargeable energy storage battery cells, a primary power source adapted to charge the energy storage cells, a switching system adapted to switch the energy storage cells between a parallel connection configuration for charging and a series connection configuration for discharging, and circuitry adapted to initiate charging of the energy storage cells only in response to an input signifying a need to discharge energy and to refrain from charging the energy storage cells until the input is received. In this way, the energy storage cells are maintained in a low charge state until discharge energy is required, the low charge state being at a level that promotes low internal self-discharge of the energy storage cells.
Abstract:
An improved 3He nuclear reactor with provision for direct electric conversion of a relativistic proton stream into useable electric power at a voltage level compatible with the national power grid (one million V DC). Various embodiments include multiple collector cages for extracting relativistic protons of various energy levels, diverter wires for deflecting high-energy proton streams to either side of lower energy cages to avoid unwanted impact. Other embodiments include arrangements for dividing multi-megavolt voltages down to a useable one megavolt level compatible with the national power grid. Further embodiments comprise guiding the proton stream by the cusps of magnetron cavities to permit conversion of the relativistic proton energies into microwave power. A proposal is also made for harvesting 3He from the Moon to supply earth-bound and space-bound reactors. A solution to the problem of charging a potential well-forming anode in an electrostatic fusion reactor without electrical arcing is further disclosed.
Abstract:
A hybrid battery power source for implantable medical use provides relatively stable resistance during discharge and avoids the voltage delays that develop as a result of variable resistance increase in Li/SVO cells. The hybrid battery power source utilizes two batteries or cells, one being a primary battery of relatively high energy density and the other being a rechargeable secondary battery of low relatively stable internal resistance. The primary and secondary batteries are connected in a parallel arrangement, preferably via an intermediate voltage boost circuit having an inductor and a pulse generating control circuit therein. The energy storage capacitors of the medical device in which the hybrid battery power source is situated are driven in whole or substantial part by the secondary battery. The primary battery is used to as an energy source for recharging the secondary battery. By arranging the two batteries in parallel, with one serving as a primary battery and the other as a rechargeable secondary battery, all the benefits of the defibrillatory impulse will be obtained and the deficiencies arising from variable voltage delay found in prior art implantable power sources will not be present.
Abstract:
An electromagnetic immune tissue invasive system includes a primary device housing. The primary device housing having a control circuit therein. A shielding is formed around the primary device housing to shield the primary device housing and any circuits therein from electromagnetic interference. A lead system transmits and receives signals between the primary device housing. The lead system is either a fiber optic system or an electrically shielded electrical lead system.
Abstract:
An implantable device used to monitor and maintain at least one physiologic function, which is capable of operating in the presence of damaging electromagnetic interference. The implantable device includes primary and secondary modules, each independently protected from EMI damage via at least one shielding and/or filtering, and a non-electrical communication device for communicating in at least one direction between the primary and the secondary modules. The primary module, in response to input from electrical sensing leads, activates the secondary module in a failsafe mode. In the failsafe mode, the secondary module carries out a physiologic function upon activation and in the presence of electromagnetic interference.
Abstract:
A cardiac pacer including a controlled voltage multiplier adapted for connection to a source of voltage to be multiplied and a plurality of parallel voltage-developing branches each including a capacitor. A pair of output terminals, at least one of which is adapted to be operatively connected to a patient's heart, are connected in series with one of the capacitors whereby the path for current charging that capacitor is through the load connected to the terminals. A corresponding plurality of controlled switches are connected to corresponding ones of the capacitors, and the switches and capacitors are connected together to define a series discharge path including the pair of output terminals when the switches are operated by a trigger pulse generator. Including timing means controlling the generation of pulses for triggering the controlled switches and thereby controlling the stimulating output pulses appearing on the pacer output terminals. The cardiac pacer can include regulating means for limiting the amplitude of the output pulses.